D3. D003 COME TOGETHER - CLINICAL ADVANCES IN PULMONARY HYPERTENSION: LESSONS FROM BEST ABSTRACTS

BPA and Riociguat for the Management of Inoperable CTEPH: Results of the Extension Study Following the RACE Randomized Controlled Trial (RCT)

Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1182 X. Jais, P. Brenot, H. Bouvaist, M. Canuet, C. Chabanne, A. Chaouat, V. Cottin, P. Degroote, N. Favrolt, D. Horeau-Langlard, M. Jevnikar, P. Magro, D. Montani, F. Parent, C. Pison, G. Prévôt, S. Renard, L. Savale, O. Sitbon, R. Trésorier, C. Tromeur, C. Piedvache, E. Fadel, M. Humbert, G. Simonneau

Switching to Riociguat from Phosphodiesterase-5 Inhibitors, With or Without Endothelin Receptor Antagonists, in Patients with Pulmonary Arterial Hypertension: Results from the REPLACE Study

Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1184 G.M. Bohns Meyer, H. Al Hiti, E. Grünig, M. Hoeper, D. Langleben, T. Pulido, S. Rosenkranz, G. Simonneau, R. White, C. Rahner, C. Meier, S. Bansilal, H. Ghofrani

PULSAR Study Open-Label Extension: Interim Results from a Phase 2 Study of the Efficacy and Safety of Sotatercept When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)

Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1185 D. Badesch, S. Gibbs, M. Gomberg-Maitland, M. Hoeper, V. Mclaughlin, I. Preston, R. Souza, A. Waxman, S. Manimaran, J. Barnes, J. de Oliveira Pena, M. Humbert